{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:18:48Z","timestamp":1792682328020,"version":"4.5.0"},"reference-count":18,"publisher":"The Microbiological Society of Korea","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Microbiol."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12275-017-7371-x","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T07:26:59Z","timestamp":1512545219000},"page":"979-983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate"],"prefix":"10.71150","volume":"55","author":[{"given":"Jin Soo","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun Bon","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Seul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Seung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Young","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Ae","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meehyein","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4586","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"7371_CR1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/135965350400900404","volume":"9","author":"Y. Abed","year":"2004","unstructured":"Abed, Y., Goyette, N., and Boivin, G. 2004. A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A\/H1N1 virus. Antivir. Ther. 9, 577\u2013581.","journal-title":"Antivir. Ther."},{"key":"7371_CR2","first-page":"483","volume":"763","author":"N. Bischofberger","year":"1998","unstructured":"Bischofberger, N., Kim, C., Lew, W., Liu, H., and Williams, M. 1998. Carboxylic compounds. U.S. patent 5,763,483.","journal-title":"Carboxylic compounds"},{"key":"7371_CR3","unstructured":"FDA 2017. The FDA approves first generic version of widely used influenza drug, Tamiflu. last updated August 04, 2016, available at https:\/\/www.fda.gov\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ ucm514854.htm."},{"key":"7371_CR4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1404.061199","volume":"14","author":"M.D. Green","year":"2008","unstructured":"Green, M.D., Nettey, H., and Wirtz, R.A. 2008. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg. Infect. Dis. 14, 552\u2013556.","journal-title":"Emerg. Infect. Dis."},{"key":"7371_CR5","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1007\/s00216-016-9483-2","volume":"408","author":"A. Grigoriev","year":"2016","unstructured":"Grigoriev, A., Borisova, I., Yaroshenko, I., and Sidorova, A. 2016. In vitro and in vivo stability of oseltamivir within a bioequivalence trial. Anal. Bioanal. Chem. 408, 3891\u20133897.","journal-title":"Anal. Bioanal. Chem."},{"key":"7371_CR6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","volume":"355","author":"L.V. Gubareva","year":"2000","unstructured":"Gubareva, L.V., Kaiser, L., and Hayden, F.G. 2000. Influenza virus neuraminidase inhibitors. Lancet 355, 827\u2013835.","journal-title":"Lancet"},{"key":"7371_CR7","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199910283411802","volume":"341","author":"F.G. Hayden","year":"1999","unstructured":"Hayden, F.G., Atmar, R.L., Schilling, M., Johnson, C., Poretz, D., Paar, D., Huson, L., Ward, P., and Mills, R.G. 1999. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N. Engl. J. Med. 341, 1336\u20131343.","journal-title":"N. Engl. J. Med."},{"key":"7371_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2016.07.024","volume":"134","author":"Y. Jang","year":"2016","unstructured":"Jang, Y., Lee, H.W., Shin, J.S., Go, Y.Y., Kim, C., Shin, D., Malpani, Y., Han, S.B., Jung, Y.S., and Kim, M. 2016. Antiviral activity of KR- 502 targeting nuclear export of influenza B virus ribonucleoproteins. Antiviral. Res. 134, 77\u201388.","journal-title":"Antiviral. Res."},{"key":"7371_CR9","first-page":"35","volume-title":"Drug-like properties: Concepts, structure design and methods from ADME to toxicity optimization","author":"E.H. Kerns","year":"2008","unstructured":"Kerns, E.H. and Di, L. 2008. Drug-like properties: Concepts, structure design and methods from ADME to toxicity optimization, pp. 35\u2013100. Academic Press, Burlington, Massachusetts, USA."},{"key":"7371_CR10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.antiviral.2013.08.002","volume":"100","author":"M. Kim","year":"2013","unstructured":"Kim, M., Kim, S.Y., Lee, H.W., Shin, J.S., Kim, P., Jung, Y.S., Jeong, H.S., Hyun, J.K., and Lee, C.K. 2013. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate. Antiviral. Res. 100, 460\u2013472.","journal-title":"Antiviral. Res."},{"key":"7371_CR11","volume-title":"Solid pharmaceutical composition comprosing oseltamivir free base","author":"S. Lee","year":"2016","unstructured":"Lee, S., Cho, J., Kim, K., Kim, Y., Park, J., and Woo, J. 2016. Solid pharmaceutical composition comprosing oseltamivir free base. PCT Patent WO2106003091."},{"key":"7371_CR12","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1021\/jm5009693","volume":"57","author":"S. Lee","year":"2014","unstructured":"Lee, S., Lim, D., Lee, E., Lee, N., Lee, H.G., Cechetto, J., Liuzzi, M., Freitas-Junior, L.H., Song, J.S., Bae, M.A., et al. 2014. Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay. J. Med. Chem. 57, 7425\u20137434.","journal-title":"J. Med. Chem."},{"key":"7371_CR13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jac\/42.5.647","volume":"42","author":"W. Li","year":"1998","unstructured":"Li, W., Escarpe, P.A., Eisenberg, E.J., Cundy, K.C., Sweet, C., Jakeman, K.J., Merson, J., Lew, W., Williams, M., Zhang, L., et al. 1998. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob. Agents Chemother. 42, 647\u2013653.","journal-title":"Antimicrob. Agents Chemother."},{"key":"7371_CR14","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1128\/JVI.01187-10","volume":"84","author":"J. Ping","year":"2010","unstructured":"Ping, J., Dankar, S.K., Forbes, N.E., Keleta, L., Zhou, Y., Tyler, S., and Brown, E.G. 2010. PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J. Virol. 84, 10606\u201310618.","journal-title":"J. Virol."},{"key":"7371_CR15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12906-017-1675-6","volume":"17","author":"T.T. Tran","year":"2017","unstructured":"Tran, T.T., Kim, M., Jang, Y., Lee, H.W., Nguyen, H.T., Nguyen, T.N., Park, H.W., Le Dang, Q., and Kim, J.C. 2017. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense. BMC Complement. Altern. Med. 17, 162.","journal-title":"BMC Complement. Altern. Med."},{"key":"7371_CR16","first-page":"687","volume-title":"Preparation of oseltamivir phosphate","author":"R. Trussardi","year":"2009","unstructured":"Trussardi, R. 2009. Preparation of oseltamivir phosphate. U.S. Patent 7,531,687."},{"key":"7371_CR17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jps.2600630512","volume":"63","author":"S.H. Wan","year":"1974","unstructured":"Wan, S.H., Pentikainen, P.J., and Azarnoff, D.L. 1974. Bioavailability of aminosalicylic acid and its various salts in humans. 3.Absorption from tablets. J. Pharm. Sci. 63, 708\u2013711.","journal-title":"J. Pharm. Sci."},{"key":"7371_CR18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.7150\/thno.17071","volume":"7","author":"X. Wu","year":"2017","unstructured":"Wu, X., Wu, X., Sun, Q., Zhang, C., Yang, S., Li, L., and Jia, Z. 2017. Progress of small molecular inhibitors in the development of antiinfluenza virus agents. Theranostics 7, 826\u2013845.","journal-title":"Theranostics"}],"container-title":["Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12275-017-7371-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-017-7371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-017-7371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:48:29Z","timestamp":1735062509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12275-017-7371-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["7371"],"URL":"https:\/\/doi.org\/10.1007\/s12275-017-7371-x","relation":{},"ISSN":["1225-8873","1976-3794"],"issn-type":[{"value":"1225-8873","type":"print"},{"value":"1976-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}